/
Improving cardiovascular outcomes in patients who receive cardio-toxic cancer therapies
Our project aims to improve the cardiovascular outcomes of Australian cancer survivors through a National Network of multidisciplinary cardio-oncology services, focussed on clinical research and patient-centred, personalised comprehensive care. This builds on the pioneering research work of the Australian Cardio-Oncology Registry and Biobank (ACOR), founded by A/Prof Conyers. This nationwide registry, including 12 tertiary institutes, is the first and best of its kind in Australia and with governance and infrastructure in place, is uniquely placed to extend its reach and improve cardiovascular health of cancer survivors, immediately.
These services will deliver centralised hubs of expertise, with protocolised risk assessment, guideline directed cardiac surveillance and enrolment within a suite of novel research studies to improve cardio-oncology outcomes, nationally.
Collaboration of NSW most eminent cardiovascular researchers. Combining expertise in the fields of heart disease, stroke, diabetes and kidney disease.
In this blog, we unmask five Heart Foundation researchers doing out-of-this-world research to save lives from heart disease.
Subscribe to updates on heart health research, including ongoing study insights and funding opportunities.
Last updated12 July 2021